58_CD Notes_NNS to_TO Group_NNP financial_JJ statements_NNS 31_CD DECEMBER_NNP 2003_CD 14_CD FIXED_VBN ASSET_NN INVESTMENTS_NNS CONTINUED_VBD The_DT cost_NN of_IN the_DT investments_NNS in_IN the_DT subsidiary_NN undertakings_NNS in_IN the_DT books_NNS of_IN the_DT Company_NN is_VBZ as_IN follows_VBZ :_: m_VB Cost_NN and_CC net_JJ book_NN value_NN at_IN 1_CD January_NNP and_CC 31_CD December_NNP 2003_CD 15.0_CD B_NNP TRADE_NN INVESTMENTS_NNS The_DT investments_NNS held_VBN during_IN 2003_CD are_VBP shares_NNS the_DT Group_NNP holds_VBZ in_IN a_DT non-related_JJ overseas_JJ listed_VBN company_NN ,_, Medivir_NNP AB_NNP ._.
2003_CD 2002_CD m_NN m_NN Cost_NN At_IN 1_CD January_NNP and_CC 31_CD December_NNP 1.5_CD 1.5_CD Amounts_NNS provided_VBN At_IN 1_CD January_NNP 1.2_CD 1.1_CD Released_VBN provided_VBN in_IN the_DT year_NN 0.5_CD 0.1_CD At_IN 31_CD December_NNP 0.7_CD 1.2_CD Net_JJ book_NN value_NN At_IN 1_CD January_NNP 0.3_CD 0.4_CD At_IN 31_CD December_NNP 0.8_CD 0.3_CD The_DT market_NN value_NN of_IN the_DT investment_NN in_IN Medivir_NNP AB_NNP at_IN 31_CD December_NNP 2003_CD was_VBD 0.8_CD m_NN 2002_CD 0.3_CD m._FW C_$ INVESTMENT_CD IN_IN OWN_NNP SHARES_NNP These_DT are_VBP shares_NNS in_IN Acambis_NNP plc_NN that_WDT have_VBP been_VBN bought_VBN by_IN an_DT employee_NN trust_NN ._.
The_DT shares_NNS may_MD be_VB issued_VBN to_TO certain_JJ employees_NNS and_CC Directors_NNS as_IN share_NN options_NNS or_CC when_WRB long-term_JJ incentive_NN awards_NNS are_VBP exercised_VBN ._.
A_DT provision_NN has_VBZ been_VBN made_VBN in_IN the_DT financial_JJ statements_NNS for_IN those_DT shares_NNS that_WDT are_VBP likely_JJ to_TO be_VB issued_VBN ._.
Group_NNP Company_NNP 2003 2002 2003 2002_CD m_FW m_FW m_FW m_FW Cost_NN At_IN 1_CD January_NNP 1.3_CD 1.6_CD 0.6_CD 0.9_CD Disposals_NNS 0.3_CD 0.3_CD Transfer_NN from_IN subsidiaries_NNS 0.7_CD At_IN 31_CD December_NNP 1.3_CD 1.3_CD 1.3_CD 0.6_CD Amounts_NNS provided_VBN At_IN 1_CD January_NNP 0.5_CD 0.4_CD 0.5_CD 0.4_CD Provided_VBN in_IN the_DT year_NN 0.5_CD 0.4_CD 0.5_CD 0.4_CD Release_NNP of_IN amounts_NNS previously_RB provided_VBD 0.1_CD 0.3_CD 0.1_CD 0.3_CD At_IN 31_CD December_NNP 0.9_CD 0.5_CD 0.9_CD 0.5_CD Net_JJ book_NN value_NN At_IN 1_CD January_NNP 0.8_CD 1.2_CD 0.1_CD 0.5_CD At_IN 31_CD December_NNP 0.4_CD 0.8_CD 0.4_CD 0.1_CD At_IN 31_CD December_NNP 2003_CD ,_, Acambis_NNP Employees_NNP Trustees_NNP Limited_NNP held_VBD 582,532_CD 2002_CD 589,685_CD ordinary_JJ shares_NNS in_IN the_DT Company_NN with_IN a_DT total_JJ market_NN value_NN of_IN 1.8_CD m_NN 2002_CD 1.6_CD m_NN on_IN behalf_NN of_IN the_DT Acambis_NNP Employees_NNP Trust_NNP ._.
All_DT shares_NNS held_VBN by_IN the_DT Trust_NNP have_VBP been_VBN allocated_VBN to_TO long-term_JJ incentive_NN awards_NNS and_CC a_DT provision_NN has_VBZ been_VBN made_VBN in_IN respect_NN of_IN all_DT of_IN these_DT shares_NNS ._.
All_DT costs_NNS relating_VBG to_TO the_DT administration_NN of_IN the_DT Trust_NNP are_VBP dealt_VBN with_IN in_IN the_DT accounts_NNS of_IN the_DT Company_NN as_IN they_PRP arise_VBP ._.
During_IN the_DT year_NN ,_, a_DT provision_NN of_IN 0.5_CD m_NN 2002_CD 0.4_CD m_NN was_VBD made_VBN in_IN relation_NN to_TO those_DT long-term_JJ incentive_NN awards_NNS whose_WP$ performance_NN criteria_NNS at_IN 31_CD December_NNP 2003_CD are_VBP expected_VBN to_TO be_VB met_VBN ._.
As_IN a_DT result_NN of_IN certain_JJ awards_NNS being_VBG forfeited_VBN during_IN the_DT year_NN ,_, there_EX was_VBD a_DT release_NN of_IN 0.1_CD m_NN 2002_CD 0.3_CD m_NN ,_, being_VBG provisions_NNS made_VBN in_IN previous_JJ years_NNS see_VBP remuneration_JJ report_NN on_IN page_NN 40_CD for_IN further_JJ details_NNS ._.
59_CD 15_CD ACQUISITION_NNP OF_IN SUBSIDIARY_NNP In_IN August_NNP 2003_CD ,_, the_DT Group_NNP acquired_VBD BPC_NNP a_DT sales_NNS ,_, promotion_NN and_CC distribution_NN organization_NN in_IN North_NNP America_NNP ._.
Acambis_NNP Inc._NNP acquired_VBD 100_CD %_NN of_IN BPCs_NNS share_VBP capital_NN for_IN 4.0_CD m_NN $_$ 6.5_CD m_NN in_IN cash_NN ,_, c._NN 1.1_CD m_NN $_$ 2.0_CD m_NN of_IN deferred_JJ consideration_NN and_CC may_MD pay_VB up_RP to_TO an_DT TM_NNP additional_JJ c._NN 1.8_CD m_NN $_$ 3.2_CD m_NN in_IN milestones_NNS from_IN 2004_CD ,_, subject_JJ to_TO the_DT achievement_NN of_IN key_JJ sales_NNS targets_NNS for_IN Vivotif_NNP and_CC ARILVAX_NNP see_VBP note_NN 3_CD below_IN ._.
The_DT fair_JJ value_NN of_IN the_DT assets_NNS purchased_VBN is_VBZ set_VBN out_RP below_IN :_: m_VB $_$ m_CD Stock_NNP 0.2_CD 0.3_CD Debtors_NNS :_: amounts_NNS receivable_NN within_IN one_CD year_NN 0.1_CD 0.2_CD Cash_NN at_IN bank_NN and_CC in_IN hand_NN 0.1_CD 0.1_CD 1_CD Creditors_NNS :_: amounts_NNS falling_VBG due_JJ within_IN one_CD year_NN 0.2_CD 0.3_CD Net_JJ assets_NNS acquired_VBD 0.2_CD 0.3_CD Net_JJ assets_NNS acquired_VBD 0.2_CD 0.3_CD Goodwill_NNP arising_VBG 6.7_CD 11.4_CD Purchase_NN consideration_NN 6.9_CD 11.7_CD Split_NN of_IN consideration_NN :_: 2_CD Cash_NN consideration_NN 4.0_CD 6.5_CD 3_CD Deferred_JJ consideration_NN 1.1_CD 2.0_CD 3_CD Contingent_JJ consideration_NN 1.8_CD 3.2_CD 6.9_CD 11.7_CD NOTES_NNS 1_CD A_DT fair_JJ value_NN adjustment_NN was_VBD made_VBN following_JJ acquisition_NN to_TO include_VB an_DT amount_NN within_IN creditors_NNS in_IN respect_NN of_IN potential_JJ stock_NN returns_NNS ._.
2_CD The_DT cash_NN consideration_NN includes_VBZ acquisition_NN expenses_NNS of_IN 0.3_CD m._NN 3_CD The_DT contingent_NN and_CC the_DT deferred_JJ consideration_NN have_VBP been_VBN discounted_VBN to_TO reflect_VB the_DT time_NN value_NN of_IN future_JJ payments_NNS ._.
The_DT total_JJ potential_JJ acquisition_NN cost_NN prior_RB to_TO discounting_VBG future_JJ cashflows_NNS is_VBZ c._JJ 7.4_CD m_NN $_$ 12.5_CD m._FW BPC_NNP has_VBZ generated_VBN turnover_NN of_IN 0.9_CD m_NN $_$ 1.6_CD m_NN and_CC operating_NN profit_NN of_IN 0.2_CD m_NN $_$ 0.4_CD m_NN from_IN date_NN of_IN acquisition_NN until_IN 31_CD December_NNP 2003_CD ._.
16_CD STOCK_NNP Group_NNP 2003_CD 2002_CD m_NN m_NN Raw_NNP materials_NNS 7.8_CD 1.1_CD Work_NN in_IN progress_NN 4.1_CD 35.0_CD Finished_VBN goods_NNS 6.3_CD 12.3_CD 18.2_CD 48.4_CD At_IN 31_CD December_NNP 2003_CD and_CC 31_CD December_NNP 2002_CD ,_, the_DT Company_NN did_VBD not_RB hold_VB any_DT stock_NN ._.
60_CD Notes_NNS to_TO Group_NNP financial_JJ statements_NNS 31_CD DECEMBER_NNP 2003_CD 17_CD DEBTORS_NNS :_: AMOUNTS_NNS RECEIVABLE_NN WITHIN_IN ONE_CD YEAR_NNP Group_NNP Company_NNP 2003 2002 2003 2002_CD m_FW m_FW m_FW m_FW A_DT Trade_NNP debtors_NNS 8.9_CD 46.1_CD Corporation_NNP tax_NN 0.2_CD Other_JJ debtors_NNS 0.3_CD 2.4_CD 0.6_CD Prepayments_NNS and_CC accrued_VBN income_NN 1.0_CD 5.3_CD Deferred_JJ tax_NN asset_NN see_VBP note_NN 10_CD 2.1_CD 12.3_CD 54.0_CD 0.6_CD 18_CD DEBTORS_NNS :_: AMOUNTS_NNS RECEIVABLE_NN AFTER_IN ONE_CD YEAR_NNP Group_NNP Company_NNP 2003 2002 2003 2002_CD m_FW m_FW m_FW m_FW Amounts_NNPS owed_VBN by_IN subsidiary_NN undertakings_NNS 28.0_CD 71.6_CD Prepayments_NNS and_CC accrued_VBN income_NN 0.1_CD 4.9_CD 0.1_CD 4.9_CD 28.0_CD 71.6_CD 19_CD CREDITORS_NNS :_: AMOUNTS_NNS FALLING_VBG DUE_JJ WITHIN_IN ONE_CD YEAR_NNP Group_NNP Company_NNP 2003 2002 2003 2002_CD m_FW m_FW m_FW m_FW Overdraft_NN facility_NN see_VBP below_IN 3.9_CD 4.3_CD B_NNP Obligations_NNS under_IN finance_NN leases_NNS 3.0_CD Trade_NNP creditors_NNS 14.5_CD 54.7_CD 0.1_CD Amounts_NNS owed_VBN to_TO subsidiary_NN undertakings_NNS 13.9_CD Corporation_NNP tax_NN 0.3_CD 0.2_CD Other_JJ taxation_NN and_CC social_JJ security_NN 0.4_CD 0.1_CD Other_JJ creditors_NNS 0.2_CD 0.1_CD 0.2_CD C_NNP Accruals_NNP and_CC deferred_JJ income_NN 74.3_CD 29.0_CD 0.5_CD 0.3_CD Deferred_NNP and_CC contingent_JJ consideration_NN 0.3_CD 96.9_CD 88.4_CD 14.6_CD 0.4_CD Under_IN the_DT terms_NNS of_IN the_DT agreement_NN between_IN Acambis_NNP and_CC Evans_NNP Vaccines_NNP Limited_NNP a_DT subsidiary_NN of_IN Chiron_NNP ,_, given_VBN certain_JJ conditions_NNS ,_, the_DT obligation_NN under_IN the_DT bank_NN overdraft_NN facility_NN of_IN 3.9_CD m_NN 2002_CD 4.3_CD m_NN for_IN part_NN of_IN the_DT costs_NNS incurred_VBN on_IN the_DT TM_NNP ARILVAX_NNP project_NN may_MD be_VB repayable_JJ within_IN one_CD year_NN ._.
The_DT facility_NN is_VBZ underwritten_VBN by_IN Chiron_NNP ._.
Chiron_NNP has_VBZ granted_VBN to_TO Acambis_NNP TM_NNP 100_CD %_NN of_IN the_DT marketing_NN rights_NNS to_TO ARILVAX_NNP in_IN the_DT US_NNP ,_, whilst_NN retaining_VBG an_DT option_NN to_TO buy_VB back_RB 50_CD %_NN of_IN the_DT profits_NNS from_IN the_DT US_NNP sales_NNS TM_NNP in_IN return_NN for_IN refunding_VBG to_TO Acambis_NNP the_DT costs_NNS that_WDT Acambis_NNP has_VBZ incurred_VBN on_IN the_DT ARILVAX_NNP program_NN ._.
The_DT overdraft_NN facility_NN was_VBD renewed_VBN in_IN January_NNP 2004_CD for_IN a_DT further_JJ year_NN ._.
Interest_NN is_VBZ charged_VBN as_RB disclosed_VBN within_IN Financial_NNP liabilities_NNS in_IN note_NN 22_CD ._.
During_IN the_DT year_NN ,_, an_DT exchange_NN gain_NN of_IN 0.4_CD m_NN 2002_CD 0.5_CD m_NN was_VBD recorded_VBN on_IN the_DT face_NN of_IN the_DT Group_NNP profit_NN and_CC loss_NN account_NN ,_, resulting_VBG from_IN the_DT revaluation_NN of_IN this_DT US_NNP dollar-denominated_JJ facility_NN ._.
20_CD CREDITORS_NNS :_: AMOUNTS_NNS FALLING_VBG DUE_JJ AFTER_IN ONE_CD YEAR_NNP Group_NNP Company_NNP 2003 2002 2003 2002_CD m_FW m_FW m_FW m_FW B_NNP Obligations_NNS under_IN finance_NN leases_VBZ 9.6_CD 14.0_CD Accruals_NNP and_CC deferred_JJ income_NN 0.1_CD 4.9_CD Deferred_NNP and_CC contingent_JJ consideration_NN 2.6_CD 12.3_CD 18.9_CD THE_DT INFORMATION_NN IN_IN THIS_NNP BORDER_NNP HAS_VBZ NOT_RB BEEN_JJ AUDITED_JJ A_DT TRADE_NN DEBTORS_NNS B_NNP OBLIGATIONS_NNP UNDER_IN FINANCE_NNP LEASES_NNP C_NNP ACCRUALS_NNPS AND_CC DEFERRED_JJ INCOME_NN THE_DT LEVEL_NN OF_IN TRADE_NN DEBTORS_NNS REDUCED_VBN DRAMATICALLY_RB IN_IN DECEMBER_NNP 2001_CD ,_, WE_NNP PUT_NNP IN_IN PLACE_NNP A_NNP FIVE-YEAR_NNP $_$ 40M_CD 49.5_CD M_NNP OF_IN DEFERRED_JJ INCOME_NN IS_VBZ INCLUDED_VBN WITHIN_IN THE_DT DURING_IN 2003_CD ._.
AT_NNP THE_DT END_NNP OF_IN 2002_CD ,_, TRADE_NN DEBTORS_NNS C._NNP 22.3_CD M_NNP FINANCE_NNP LEASE_NNP FACILITY_NNP IN_IN RESPECT_NNP OF_IN THE_DT TOTAL_JJ HERE_RB OF_IN 74.3_CD M_NNP ,_, WHICH_WDT REPRESENTS_VBZ THE_DT DIFFERENCE_NN PRINCIPALLY_RB REPRESENTED_VBD AMOUNTS_NNS OWED_VBN BY_IN THE_DT CDC_NNP REACTIVATION_NNP OF_IN OUR_NNP MANUFACTURING_NNP PLANT_NNP ._.
AT_NNP THE_DT END_NN BETWEEN_IN INVOICES_NNS SUBMITTED_VBN TO_TO THE_DT CDC_NNP UNDER_IN ITS_NNP TO_TO ACAMBIS_NNP UNDER_IN ITS_NNP 155_CD MILLION-DOSE_JJ SMALLPOX_NNP OF_IN 2003,12.6_CD M_NNP $_$ 22.5_CD M_NNP WAS_NNP OWED_VBD UNDER_IN THIS_NNS FACILITY_NN ,_, $_$ 428M_CD C._NNP 240M_NNP SMALLPOX_NNP VACCINE_NNP CONTRACT_NNP AND_CC VACCINE_NNP CONTRACT_NNP THAT_WDT WERE_VBD PAID_NNP IN_IN EARLY_NNP 2003_CD ._.
ALL_NNP CAPITAL_NNP AMOUNTS_NNP RECORDED_VBD AS_IN REVENUE_NNP IN_IN THE_DT PERIOD_NN 2001_CD OBLIGATIONS_NNP UNDER_IN THIS_NNP LEASE_NNP WILL_MD BE_VB DISCHARGED_NNP TO_TO 2003_CD ._.
WE_NNP EXPECT_VB THIS_NNP AMOUNT_NNP WILL_MD SUBSTANTIALLY_RB IN_IN THE_DT PERIOD_NN 2004_CD TO_TO 2006_CD ._.
